Stacy Blain

Stacy Blain, co-founder and Chief Scientific Officer of Concarlo Therapeutics, discusses drug resistance in cancer and the development of therapies to target drug-resistant breast cancer. The chapter also explores the role of P27 protein in cancer biology and the challenges faced by women in the biotech industry. The speaker provides insights into the company's funding journey and upcoming research and clinical trials.